On August 7, Astera Labs, Inc. rose 3.47% in pre-market trading, trading at $337.73/share, with turnover of $702,900.
The stock continues to benefit from a wave of institutional upgrades and robust Q2 earnings momentum. RBC Capital raised its target price from $425 to $500, maintaining an Outperform rating — the highest target among recent institutional revisions. Morgan Stanley previously raised its target from $240 to $335, and Barclays lifted its target to $325, reflecting broad analyst consensus on the high-speed connectivity chip segment.
The company reported Q2 adjusted EPS of $0.80, significantly beating the $0.69 consensus estimate, with revenue of $392.4 million surpassing the $360.7 million expectation and roughly doubling year-over-year. More critically, Q3 revenue guidance of $540-560 million far exceeded the prior consensus of $417 million, underscoring accelerating AI infrastructure connectivity demand. After a 7%-plus pullback driven by profit-taking on August 5, the stock has resumed its upward trajectory as institutional catalysts continue to offset short-term selling pressure.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments